Effects of gender-affirming hormone therapy on cardiovascular risk factors focusing on glucose metabolism in an Austrian transgender cohort.
Carola DeischingerDorota SlukovaIvica JustUlrike KaufmannJuergen HarreiterMick van TrotsenburgSiegfried TrattnigMartin KrššákAlexandra Kautzky-WillerRadka KlepochovaLana Kosi-TreboticPublished in: International journal of transgender health (2022)
In AMAB, most investigated parameters adapted to levels seen in cisgender females except for parameters related to fasted insulin resistance. AMAB should be monitored with respect to the development of insulin resistance.
Keyphrases
- insulin resistance
- cardiovascular risk factors
- metabolic syndrome
- adipose tissue
- high fat diet
- polycystic ovary syndrome
- cardiovascular disease
- skeletal muscle
- type diabetes
- high fat diet induced
- mental health
- hiv testing
- glycemic control
- atomic force microscopy
- hepatitis c virus
- hiv infected
- men who have sex with men
- human immunodeficiency virus
- mass spectrometry
- high speed